(Q33223401)

24 July 2017

Fas (CD95) and bcl-2 expression in active skin lesions of Behçet's disease (English)

1 reference

24 July 2017

0 references

Bariş YS

1

1 reference

24 July 2017

Yildiz L

series ordinal

2

1 reference

24 July 2017

Sentürk N

series ordinal

3

1 reference

24 July 2017

Kandemir B

series ordinal

4

1 reference

24 July 2017

1 September 2005

1 reference

Journal of the European Academy of Dermatology and Venereology

24 July 2017

1 reference

24 July 2017

19

1 reference

24 July 2017

5

1 reference

24 July 2017

569-572

1 reference

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

24 July 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01250.X

bcl-2: role in epithelial differentiation and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01250.X

Expression of bcl-2 protein in active skin lesions of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01250.X

Levels of soluble Fas/APO-1 in patients with Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01250.X

10.1111/J.1468-3083.2005.01250.X

21 January 2018

Identifiers

DOI

1 reference

24 July 2017

1 reference